Treatment of Morbihan disease
- Document Type
- Publications · Journal Article
- Registered DB
- KCIScopus
- Journal Ranking
- Scopus Q4KCI Q2
- Journal
- Archives of Craniofacial Surgery22(3) · pp.131 · 2021
- Citation
- Scopus 14KCI 1
- FWCI (Scopus)
- 1.82
- ISSN
- 2287-1152
Authors
- Kim, Joo-hyungFirst authorCorresponding authorDepartment of Plastic and Reconstructive Surgery, Pusan National University School of Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, Korea
Abstract
Morbihan disease (MD) is a rare condition that involves rosaceous lymphedema or erythematous lymphedema of the middle and upper thirds of the face. It typically affects the periorbital region, forehead, glabella, nose, and cheeks. The etiology of MD remains unclear, and its diagnosis is challenging. MD often tends to be unresponsive to therapies commonly used to treat rosacea, including corticosteroids, isotretinoin, and antibiotics. Surgical treatments have therefore been attempted, but most cases showed unsatisfactory responses. These problems could have resulted from an incorrect recognition and interpretation of the pathophysiology of MD and inaccurate planning of the operation, resulting in recurrence or exacerbation of edema.
Keywords
Identifiers
- Scopus EID
- 2-s2.0-85110446590
- KCI
- ART002725503



Login
Back to Publication list